BIIB
Biogen IncNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$27.64B
P/E Ratio
20.13
EPS
$9.30
Beta
0.20
52W High
$202.41
52W Low
$115.25
50-Day MA
$184.62
200-Day MA
$164.74
Dividend Yield
—
Profit Margin
13.80%
Forward P/E
13.40
PEG Ratio
3.94
About Biogen Inc
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Fundamentals
| Revenue (TTM) | $9.94B |
| Gross Profit (TTM) | $7.82B |
| EBITDA | $3.52B |
| Operating Margin | 22.90% |
| Return on Equity | 7.70% |
| Return on Assets | 5.90% |
| Revenue/Share (TTM) | $67.70 |
| Book Value | $126.37 |
| Price-to-Book | 1.48 |
| Price-to-Sales (TTM) | 2.78 |
| EV/Revenue | 3.009 |
| EV/EBITDA | 11.08 |
| Quarterly Earnings Growth (YoY) | 31.10% |
| Quarterly Revenue Growth (YoY) | 1.90% |
| Shares Outstanding | $147.64M |
| Float | $147.16M |
| % Insiders | 0.18% |
| % Institutions | 97.73% |
Historical Volatility
HV 10-Day
40.99%
HV 20-Day
36.26%
HV 30-Day
37.01%
HV 60-Day
36.73%
HV Rank
72.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($217.03 target)
2
Strong Buy17
Buy16
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/5/2026